Epidemiology of Cold Agglutinin Disease

Prev
 1 / 21 
Next
Prev
 1 / 21 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • explain why CAD epidemiologic estimates vary
  • distinguish primary CAD from related entities affecting prevalence data
  • recall practical clinical anchor numbers
  • recognize demographic patterns consistent with CAD biology
  • interpret epidemiologic findings cautiously in rare disease
  • apply epidemiologic reasoning to clinical scenarios

Why do published incidence estimates for CAD vary substantially?

a
The disease incidence fluctuates seasonally
Seasonal symptoms do not change incidence.
b
Case definitions and data sources differ
Definitions, coding, and ascertainment methods strongly influence estimates.
c
Most cases spontaneously resolve
CAD is chronic, not self-limited.
d
Diagnostic testing is unreliable
Testing is generally reliable when used appropriately.

Which entity is most likely to be conflated with primary CAD in administrative datasets, inflating prevalence estimates?

a
Paroxysmal nocturnal hemoglobinuria
Distinct disorder with separate coding.
b
Secondary cold agglutinin syndrome
Administrative datasets often collapse primary CAD and secondary CAS.
c
Pure complement deficiency
Not part of CAD epidemiology.
d
Warm autoimmune hemolytic anemia
Usually coded separately and pathobiologically distinct.

What is the most useful incidence anchor for classic primary CAD cohorts?

a
1 per 10,000 per year
Too high.
b
~1 per 1,000,000 per year
Carefully phenotyped cohorts suggest ~1 per million annually.
c
1 per 100 per year
Not compatible with rare disease.
d
1 per 10 per year
Implausible.

Which demographic pattern best aligns with CAD biology?

a
Pediatric predominance
CAD is rare in children.
b
Equal incidence across ages
Incidence rises with age.
c
Presentation primarily after age 50
Age distribution reflects accumulation of clonal B-cell populations.
d
Peak incidence in adolescence
Not observed.

Approximately what proportion of AIHA cases does CAD represent?

a
15–25%
CAD represents a minority but substantial subset of AIHA.
b
<1%
Underestimate.
c
5%
Too low.
d
>50%
Too high.

Why might administrative database studies report higher CAD prevalence than adjudicated cohorts?

a
CAD incidence has surged recently
No evidence of surge.
b
Broader coding definitions and inclusion of related conditions
Coding practices and broader inclusion inflate estimates.
c
Improved cure rates
Treatment does not alter prevalence this way.
d
Genetic screening programs
Screening is not widespread.

When is overlap of control and modification strategies most justified?

a
Newly diagnosed CAD
New diagnosis alone does not define the clinical goal that would justify overlapping strategies.
b
Mild asymptomatic disease
Combination increases risk unnecessarily.
c
Acute hemolysis with long-term remission goal
Immediate control plus long-term modification addresses different time horizons.
d
Patient request for aggressive treatment
Preference alone does not justify escalation.

Which statement best captures the relationship between climate and CAD epidemiology?

a
Cold climates increase disease incidence
Evidence inconsistent.
b
Warm climates eliminate risk
CAD occurs globally.
c
Geography determines antibody production
No evidence.
d
Climate likely affects symptom expression more than true incidence
Climate may influence detection and manifestation more than biology.

Why can epidemiologic data not replace diagnostic evaluation in a patient with suspected CAD?

a
The disease is rare
Rarity alone does not explain diagnostic uncertainty.
b
Estimates vary across studies
Variation reflects methodological differences but does not explain an individual patient’s diagnosis.
c
Secondary causes are common but inconsistently distinguished
Epidemiologic studies cannot reliably distinguish primary vs secondary disease in a given case.
d
Prevalence is low
Low prevalence does not determine diagnostic category.

Why are low-titer cold agglutinins not equivalent to CAD?

a
They occur only in children
Occur at all ages.
b
They often do not cause hemolysis
Many are transient and clinically insignificant.
c
They cannot be detected
They are detectable.
d
They always indicate malignancy
Most are benign.

Which principle best captures rare-disease epidemiology as described in this essay?

a
Biology alone determines estimates
Biology matters but is not sufficient.
b
Estimates reflect both biology and the methods used to define and detect cases
Epidemiology reflects methodology as much as disease.
c
Estimates are always precise when cohorts are large
Precision is limited in rare disease.
d
Incidence and prevalence are interchangeable
These are distinct metrics.

A 22-year-old presents with mild anemia and a positive cold agglutinin titer two weeks after a respiratory infection. Interpretation?

a
Confirms primary CAD
Primary CAD is chronic and clonal.
b
Likely transient post-infectious agglutinins
Post-infectious cold agglutinins are common and often transient.
c
Administrative datasets would exclude this case
Such cases are often included, inflating estimates.
d
Immediate clone-directed therapy is indicated
No indication for clone therapy.

A registry reports prevalence 8/million for a rare disease; claims data report 50/million. Most likely explanation?

a
Registry used outdated diagnostics
No evidence.
b
True prevalence surge
Possible but unlikely explanation.
c
Claims data are always more accurate
Claims reflect coding, not necessarily biology.
d
Differences in case definition and ascertainment
Methodology commonly explains discrepancies.

Sort each item into the correct category.

Transient cold agglutinins
Primary chronic CAD
Administrative dataset
Adjudicated cohort
Secondary CAS
Mixed AIHA
True primary CAD entity
Related but distinct conditions
Methodologic estimate types

Match each concept to its implication:

Administrative coding
Older age distribution
Strict phenotyping
Lower incidence estimates
Clonal biology
Higher apparent prevalence
Correct! Sorry, Incorrect.

Closing Note

Cold agglutinin disease is rare, but rarity is not a fixed number.

Epidemiologic estimates describe not only the disease, but how we define it, detect it, and count it. Expert clinicians therefore treat epidemiology as orientation, not certainty.

Prev
 1 / 21 
Next